Thorac Cardiovasc Surg 2020; 68(03): 219-222
DOI: 10.1055/s-0039-1677836
Original Cardiovascular
Georg Thieme Verlag KG Stuttgart · New York

Pericardial fluids or Cardiopulmonary Bypass—Is There a Major Culprit for Changes in Coagulation and Inflammation?

Hagen Gorki
1   Herz-, Thorax- und Gefäßchirurgie, Universitätsklinik Ulm, Ulm, Germany
,
Julia Nakamura
1   Herz-, Thorax- und Gefäßchirurgie, Universitätsklinik Ulm, Ulm, Germany
,
Andreas Kunert
1   Herz-, Thorax- und Gefäßchirurgie, Universitätsklinik Ulm, Ulm, Germany
,
Markus Hoenicka
1   Herz-, Thorax- und Gefäßchirurgie, Universitätsklinik Ulm, Ulm, Germany
,
Andreas Liebold
1   Herz-, Thorax- und Gefäßchirurgie, Universitätsklinik Ulm, Ulm, Germany
› Institutsangaben
Weitere Informationen

Publikationsverlauf

31. Juli 2018

21. Dezember 2018

Publikationsdatum:
06. Februar 2019 (online)

Abstract

Background From the results of a previous study, it remained to be investigated if a perioperative rise of few tested coagulation and inflammation markers is caused by conventional cardiopulmonary bypass (CPB) itself or rather by direct recirculation of pericardial fluids.

Methods Forty-eight patients operated on with conventional CPB for myocardial revascularization were randomized either for direct recirculation of pericardial suction fluids or for cell saving (CS).

Results Thrombin–antithrombin complexes showed lower values intraoperatively in the CS group (p < 0.0001), and D-dimers tended to remain lower at intensive care unit arrival (p = 0.095). Tests of inflammation markers were less meaningful.

Conclusion Direct recirculation of pericardial fluids rather than conventional CPB itself causes major intraoperative changes of some coagulation markers. Pericardial blood loss with direct recirculation should be kept to a minimum to avoid unnecessary activation of coagulation. Inflammation markers need further investigations.

Note

This article was presented as a poster at the 46th annual meeting of the German Society for Thoracic and Cardiovascular Surgery in February 2017, Leipzig, Germany.


 
  • References

  • 1 Gorki H, Hoenicka M, Rupp P. , et al. Similarity of coagulation and inflammation despite different surgical revascularization strategies - a prospective randomized trial. Perfusion 2016; 31 (08) 640-647
  • 2 Chung JH, Gikakis N, Rao AK, Drake TA, Colman RW, Edmunds Jr LH. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation 1996; 93 (11) 2014-2018
  • 3 Sniecinski RM, Chandler WL. Activation of the hemostatic system during cardiopulmonary bypass. Anesth Analg 2011; 113 (06) 1319-1333
  • 4 Nakahira A, Sasaki Y, Hirai H. , et al. Cardiotomy suction, but not open venous reservoirs, activates coagulofibrinolysis in coronary artery surgery. J Thorac Cardiovasc Surg 2011; 141 (05) 1289-1297
  • 5 Morisaki A, Nakahira A, Sasaki Y. , et al. Is elimination of cardiotomy suction preferable in aortic valve replacement? Assessment of perioperative coagulation, fibrinolysis and inflammation. Interact Cardiovasc Thorac Surg 2013; 17 (03) 507-514
  • 6 Prieto MA, Guash S, Mendez JC, Munoz C, Planas A, Reyes G. Does use of cell saver decrease the inflammatory response in cardiac surgery?. Asian Cardiovasc Thorac Ann 2013; 21 (01) 37-42
  • 7 Bauer A, Hausmann H, Schaarschmidt J. , et al. Shed-blood-separation and cell-saver: an integral part of MiECC? Shed-blood-separation and its influence on the perioperative inflammatory response during coronary revascularization with minimal invasive extracorporeal circulation systems - a randomized controlled trial. Perfusion 2018; 33 (02) 136-147